Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?
Published inJournal of Antimicrobial Chemotherapy, vol. 72, no. 3, p. 866-875
Publication date2017
Abstract
Keywords
- Cohort Studies
- Drug Resistance
- Viral/genetics
- Genes
- Gag
- Genotype
- HIV Infections/blood/drug therapy/virology
- HIV Protease/genetics
- HIV Protease Inhibitors/pharmacology/therapeutic use
- HIV-1/drug effects/genetics
- Humans
- Mutation
- Missense
- Prevalence
- RNA
- Viral/blood
- Sequence Analysis
- DNA
- Switzerland
- Treatment Failure
- Gag Gene Products
- Human Immunodeficiency Virus/genetics
Affiliation entities
Research groups
Citation (ISO format)
KLETENKOV, K et al. Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors? In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, n° 3, p. 866–875. doi: 10.1093/jac/dkw493
Main files (1)
Article (Published version)
Identifiers
- PID : unige:99804
- DOI : 10.1093/jac/dkw493
- PMID : 27999036
Journal ISSN0305-7453
